Published in JAMA · View the paper (DOI)
A study found that anti-inflammatory drugs like abatacept and infliximab reduced mortality in severely ill COVID-19 patients when used with standard care. However, these medications did not affect recovery time. The findings suggest that multiple treatment options are available for severe cases of COVID-19.
Coverage from 2 institutions